Table 2.
RFCA (n = 125) |
CBA (n = 97) |
TTA (n = 131) |
p-Value | |
---|---|---|---|---|
Procedure duration (min) | 139 ± 34 | 90 ± 20 | 157 ± 39 | <0.001 |
Fluoroscopy time (min) | 25 ± 11 | 29 ± 10 | - | 0.010 |
Length of hospital stay (days) | 3.7 ± 0.6 | 3.8 ± 0.9 | 10.2 ± 4.7 | <0.001 |
Pulmonary vein isolation | 125 (100%) | 97 (100%) | 131 (100%) | |
Roof line | 51 (42%) | 0 (0%) | 120 (92%) | |
Posterior line | 46 (37%) | 0 (0%) | 129 (99%) | |
Mitral isthmus line | 33 (32%) | 0 (0%) | 0 (0%) | |
Endocardial CS | 17 (17%) | 0 (0%) | 0 (0%) | |
SVC isolation | 18 (18%) | 0 (0%) | 52 (40%) | |
CTI line | 84 (68%) | 7 (8%) | 0 (0%) | |
Ganglionic plexi | 0 (0%) | 0 (0%) | 118 (90%) | |
LAA exclusion | 0 (0%) | 0 (0%) | 128 (98%) |
RFCA, radiofrequency catheter ablation; CBA, cryoballoon ablation; TTA, totally thoracoscopic ablation; CS, coronary sinus; SVC, superior vena cava; CTI, cavotricuspid isthmus; LAA, left atrial appendage.